Maximum Attendees Interactive Sessions Networking Hours About the Event Biopharma APAC Confex is Asia-Pacific’s most comprehensive decision-maker-only biopharma conference and exhibition , bringing together 2,000+ attendees and 700+ companies across six co-located specialist conferences. Covering multiple biopharma modalities and critical functions across the drug development and manufacturing value chain, the Confex brings together communities spanning biologics manufacturing, clinical development, ADCs, cell & gene therapy, oligonucleotides & peptides, and biopharma supply chain . What makes Biopharma APAC Confex different is both the breadth of the ecosystem it covers and the quality of the audience it brings together . Every biopharma attendee is a decision-maker, creating a highly focused environment for knowledge exchange, technology discovery, meaningful conversations and strategic partnerships. Through six specialist conferences, a focused exhibition, partnering, curated networking, awards and social experiences, Biopharma APAC Confex connects biopharma leaders with technology innovators, CDMOs and solution providers from across Asia-Pacific. ‍ Six specialist conferences. Multiple biopharma modalities. 100% decision-makers. One connected APAC biopharma ecosystem. Visit the event page to view more content. Biologics Manufacturing Asia 2027 Clinical Trials Festival Asia 2027 BioSupply Chain Asia 2027 ADC Asia Congress 2027 Cell & Gene Therapy World Asia 2027 Oligos & Peptides World Asia 2027 Awards Cerermony Visit the awards page to view more content. Asia-Pacific Biopharma Excellence Awards 2027 Agenda at a Glance View the Key Themes for Biopharma Asia Pacific Conference, Exhibition & Awards 2027 Explore the latest breakthroughs in single-use systems, end-to-end continuous processing, and next-generation biologics manufacturing innovations that will redefine efficiency. Gain practical insights into upstream and downstream process improvements, from cost reduction to timeline acceleration, to ensure your biologics pipeline stays competitive and robust. Stay ahead of changing regulations with updates from international regulators and big pharma, ensuring you meet evolving requirements and quality standards across Asian markets. Discover new opportunities in manufacturing advanced biologics and novel modalities, and learn how to overcome current challenges to unlock the full potential of next-generation therapies. Connect with Asia’s top biopharma leaders and global experts through a carefully curated networking platform designed to spark strategic partnerships and drive industry collaborations Ready to attend? Register today to secure your ticket. Esteemed Voices From the Industry Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Want to Speak at This Event? Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry. With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent; a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognised names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD: Visit bd.com ‍ Connect with us on LinkedIn at www.linkedin.com/company/bd1/ ‍ X (formerly Twitter) @BDandCo ‍ Instagram @becton_dickinson WuXi Biologics is a leading global CRDMO, with the R represented by our premium-quality CRO Services. With expertise in diverse drug modalities, we deliver comprehensive research services, including antibody discovery, protein production and engineering, and in vitro and in vivo testing, to seamlessly advance our clients’ molecules from concept to CMC development. Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies. Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC. Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes. Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally. For more information about Pfanstiehl Inc, and their products and solutions, please contact us at cs@pfanstiehl.com or visit www.Pfanstiehl.com BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a strategic interest in specific therapeutic areas. In a campus of approximately 60 acres, with approximately 650,000 sqf built surface, the facility is designed to handle conventional small molecules, Biologics and ADCs (from Conjugation to Fill Finish) and very much focused on innovative compounds. With full containment facility, applying the most advanced and safe technologies, BSP can offer a wide range of services for Pre-Clinical, Clinical and Commercial supply in compliance with the highest Quality requirements. BSP is positioned as a centre of excellence and a valued strategic partner among those small and large pharma and biotech companies with an advanced outsourcing process for strategic products with a high technological content. Nona Biosciences provides integrated solutions for antibody discovery and development. Using proprietary Harbour Mice® platforms that generate fully human H2L2 and HCAbs, we support diverse therapeutic formats. From immunization to IND-enabling services, our platforms and tailored solutions empower partners to move efficiently from idea to IND with flexibility and confidence. Exhibition & Showcase PharmNXTBiotech is a young Biotech Start-up based in Mumbai, it was established in the year 2017 with the idea of creating end-to-end bioprocess solutions and providing niche technologies to help reduce manufacturing costs for critical lifesaving drugs. We recently inaugurated PharmNXTEkuse our brand new state-of-the-art single manufacturing facility based in Pune, which houses end-to-end solutions for the biopharma, vaccines manufacturing and containment solutions . With the vision of “ Make in India for the World ,” we are ready to showcase our Xelta range of Single Use 2D, 3D bags and NXTmix Levitating mixing solutions along with our hardware technologies for downstream processing. For containment solutions, we have our Make in India products: Flexible Isolators, Rigid Isolators as well as Powder Transfer Bags to handle potent molecules. Founded in 2000, Truking Technology is a pioneering leader in China’s pharmaceutical equipment industry and a globally recognized innovator. We specialize in integrated intelligent solutions for smart pharmaceutical plants and core pharmaceutical equipment. With dual headquarters in China and Germany—along with subsidiaries worldwide including Germany's ROMACO Group—we leverage a global R&D network and over 4,900 patents to serve more than 180 countries and regions. Our technology has shaped over 20 national industry standards, enabling intelligent transformation across the global pharmaceutical sector. Driven by the vision to build a trillion-yuan industrial chain in biopharmaceuticals and life sciences, we are expanding into advanced biomaterials and gene technology. Guided by our core values of "Respected People, Respected Products, Respected Enterprise," we commit to empowering the worldwide pharmaceutical industry through intelligent innovation. Truking strives to become a global leader in pharmaceutical equipment by around 2030—bringing Chinese intelligent manufacturing to the world stage. Tosoh Corporation is a global chemical and specialty materials company. The company was founded in 1935 in Yamaguchi Prefecture, as Toyo Soda Manufacturing Co., Ltd., and in 1987 changed its name to Tosoh Corporation. Today, its corporate headquarters are in Tokyo, Japan. Single Use Support provides innovative fluid management products and services around single-use technologies for the pharmaceutical industry. Their solutions reduce product loss of liquid substances for the biopharmaceutical market towards 0%. With their proven experience they provide partners with fast and professional solutions including sterile single-use consumables, freeze-thaw & fill-filtration platform systems and end-to-end process solutions. Their product range includes bioprocess containers, single-use assemblies, protective single-use bag shells (RoSS® Shell), Freeze & Thaw Platforms, Fill & Drain Platforms, Ultra-Cold Storage Freezers, Trackable Cold-Chain Shipping Boxes and more. Single Use Support is headquartered in Austria, Europe, and has a subsidiary in the United States. In addition, they are operating on a global scale with a close network of distributors and partners. Established since 1982, Dou Yee Enterprises is a dynamic and comprehensive supplier committed to transform the landscape for medical pharmaceutical, and healthcare services sectors. From cutting-edge medical equipment to essential ancillary products, medical packaging solutions, environmental control products and pharmaceutical drugs, Dou Yee Enterprises is your holistic partner for integrated pharmaceutical manufacturing environment. FUNDAMIX® Vibro-Mixer uses an electromagnetic drive to oscillate a mixing plate and generate axial flow, without any rotating parts or mechanical seals. The flow direction can be inverted by adjusting the plate orientation, enabling precise control over mixing characteristics and intensity. This versatile, low-maintenance and highly-reliability design ensures gentle but effective agitation across a wide range of applications Duoning Biotech is a leading one-stop bioprocess solutions provider from China, committed to offering products and services required for the discovery, development and commercialization production of biologics, including reagents, consumables, instruments, equipment, and services. Leveraging our integrated bioprocess system, we empower our customers to achieve effective, reliable, lower-cost and higher-quality biologics manufacturing processes. We provide over 240 products and more than 140 services for applications in antibodies, CGT, vaccines, and other areas, serving a global customer base of more than 3000 customers, including pharmaceutical companies, CRO/CDMOs, and research institutions. HyQure BioTech Co., Ltd. (HYQURE) is a technology-driven, one-stop biosafety CRO specializing in viral safety and quality control for biologics and cell & gene therapy products. From discovery through commercial launch, we provide GLP/GMP-aligned viral clearance and inactivation studies, cell bank characterization, raw material testing, AAV and other viral vector characterization, process residue (HCP/HCD) detection, analytical method validation, and total solutions for cell/virus bank manufacturing and storage. With ISO9001 and CNAS accredited BSL-2 laboratories across China and a newly opened European lab in Basel, Switzerland, HYQURE supports 400+ global clients and 130+ regulatory submissions, helping de-risk CMC and accelerate IND/BLA approvals for innovative biopharmaceutical and CDMO partners. Meissner Corporation manufactures advanced microfiltration products and therapeutic manufacturing systems for critical pharmaceutical and biopharmaceutical applications, such as sterilization of injectable drugs, and the development and manufacture of life- enhancing/life-saving drugs, therapeutics, biologics, and cell and gene therapies. Meissner’s manufacturing campuses include a headquarters location in Camarillo, California, USA, a European manufacturing location in Castlebar, Ireland, and the buildout of a new $250 million manufacturing site in Athens, Georgia. Meissner’s global customer base is serviced through local representation worldwide. For more information about Meissner, please visit www.meissner.com or call +1.805.388.9911. Since 1998, APPL is in the business of Silicone Elastomeric product and also other Polymeric components which ultimately provide to Fluid Transfers, Sealing and Contamination controls for Biopharma, Pharma, Medical, Laboratory, Food, Beverages and Engineering sectors worldwide. APPL is having ISO Class 7 & 8 cleanroom facilities certified with ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 15378:2017, ISO 13485: 2016. We also have a BPOG extractable program for our products for regulatory markets. APPL has world class manufacturing technology with end to end process capabilities to fulfil the needs of the customers, which include Extrusion Technology with laser Controlled system, Automatic Hose Production lines, Plastic Extrusion Lines, Automatic Hydraulic Presses for Elastomer & Polymeric Components, Laboratory with R&D Equipment, In-House Tooling & Mould making machinery, Laser Cut Machines and Online Printing as well as Marking systems on Products. As a multi-disciplinary business consultancy, we provide technical and digital transformation services designed to help your organization thrive amidst the complexities and uncertainties of today’s global marketplace. Our approach is rooted in a deep understanding of your business needs while leveraging technology and best practices to ensure your business stays ahead of the curve. Discover the ORKA difference — solutions and services built for resilience, adaptability, and results. INFORS HT is a Swiss company with over 60 years of experience developing innovative solutions that support researchers and bioprocess professionals worldwide. Our portfolio is built on three core pillars: the eve® bioprocess platform , incubator shakers , and bioreactors , providing an integrated ecosystem for bioprocess development and cultivation. By combining reliable hardware with intelligent software, we help customers simplify workflows, improve reproducibility, and accelerate scientific innovation. 3CON Life Science: Single-Use Systems & Automation for Pharma, Biopharma & Medtech 25+ years of scalable manufacturing solutions for life sciences, automotive & high-tech industries. Competencies: + Single-Use Consumables: laser-welded 2D/3D bio-process containers + Agnostic Platform Systems: vendor-independent, resilient supply chain + Medical Device Manufacturing: precision, cleanroom-compatible, validated Innovation meets integrity – your industrial foundation for biopharma breakthroughs. ‍ ‍ About GenScript Biotech Corporation: Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has a team of over6,100employees and has served more than 265,000 customers across over 100 countries and regions. Learn more here: https://www.genscript.com About PROBIO ProBio, a subsidiary of GenScript Biotech Corporation, is a global Contract Development and Manufacturing Organization (CDMO) that accelerates the discovery, development, and commercialization of biologics and advanced therapies. Combining innovative discovery platforms with integrated development and GMP manufacturing capabilities, ProBio provides end-to-end solutions across antibodies, recombinant proteins, plasmid DNA, mRNA, viral vectors, and in vivo CAR-T therapies. ProBio website: https://www.probiocdmo.com/ UniqCulture is an emerging biotech industry focused on developing high-quality powdered cell culture media, serum-free media, and distribution of animal serum for the biopharma and vaccine industries. With strong R&D expertise, tech support and a mission to reduce India’s dependency on imports, UniqCulture aims to offer consistent, affordable, and indigenous solutions for accelerating life science innovation and manufacturing. CATALENT PHARMA SOLUTIONS 14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873 About Catalent Clinical Supply Services Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries. Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world. For 44 years, QuickSTAT has been providing the leading pharma and biotech companies 24/7/365 global life science logistics solutions from R&D, clinical trials through to commercialization. Our logistics experts provide time-and temperature-sensitive transport of clinical research samples, cell and gene therapies, investigational drugs, clinical trial supplies and vaccines, to bring new drugs to market. Strict chain of custody, chain of identity and GDP protocols ensure product integrity and patient safety for all clinical and commercial personalized medicines QuickSTAT transports. Consultation and procurement of proper packaging—from controlled room temperature to cryo-frozen. Next-gen IT logistics software provided for managing your clinical supply chain with real-time temperature and tracking technology. Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution. We are recognised as an industry leader in client service, providing understanding, experience and knowledge to our clients as we work together to advance human health.Almac is trusted by the leading global biopharma companies to provide crucial services across their drug development projects. In the last 6 years alone, we have contributed to over 50% of all FDA approved New Molecular Entities (NMEs) and are currently supporting 30% of EU approved /pre-registered Gene therapy products. A privately owned organisation, Almac has grown organically over the past five decades, employing over 7,900 highly skilled employees across 18 facilities in Europe, North America, and Asia.

Honya Biotech specializes in the R&D, production, and sales of oligonucleotide synthesis and processing equipment, raw materials and consumables. We deliver highly flexible and efficient end-to-end oligosynthesis solutions and exceptional technical service worldwide. Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution. We are recognised as an industry leader in client service, providing understanding, experience and knowledge to our clients as we work together to advance human health.Almac is trusted by the leading global biopharma companies to provide crucial services across their drug development projects. In the last 6 years alone, we have contributed to over 50% of all FDA approved New Molecular Entities (NMEs) and are currently supporting 30% of EU approved /pre-registered Gene therapy products. A privately owned organisation, Almac has grown organically over the past five decades, employing over 7,900 highly skilled employees across 18 facilities in Europe, North America, and Asia. Media & Publicity Trusted by Industry Leaders Select the relevant ticket for your organisation. *Delegate tickets must be purchased under the correct classification. Biopharma tickets are strictly reserved for professionals employed by pharmaceutical or biopharmaceutical companies that develop, own, or commercialise therapeutic drug products, including organisations with an internal drug pipeline spanning discovery, development, clinical, or commercial stages. This category applies to companies whose primary business is the development or manufacture of drug products, not the provision of enabling technologies, equipment, platforms, or services. Service, Solution, and Technology Provider tickets apply to all organisations offering services, platforms, technologies, equipment, consultancy, manufacturing services, or commercial solutions to the pharma and biopharma industry. This includes, but is not limited to, CROs, CDMOs, technology and equipment vendors, consultants, suppliers, and solution providers, regardless of scientific or technical focus. Important Notice All registrations are reviewed to ensure correct classification. Purchasing an incorrect ticket does not guarantee entry to the event. IMAPAC retains full discretion to deny access, reclassify registrations, and issue an invoice for the price difference required for correct attendance. Incorrect ticket purchases made under an inappropriate classification are not eligible for refunds under any circumstances, including where the registrant chooses not to upgrade or attend. Early Bird Rate : SGD 1,495 Use discount code: EARLYBIRD ‍ (Valid until 3rd October 2026) ‍ Registration Open Rate : SGD 1,695 Use discount code: REGISTRATIONOPEN ‍ (Valid until 5th December 2026) ‍ Standard Rate : SGD 1,895 Use discount code: STANDARD ‍ (Valid until 6th February 2026) ‍ Final Call Rate : SGD 2,095 ‍ ‍Applicable to company profiles (headquartered within the APAC region): Academic Institutions Research Organisations ‍Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations Early Bird Rate : SGD 1,995 Use discount code: EARLYBIRD ‍ (Valid until 3rd October 2026) ‍ Registration Open Rate : SGD 2,195 Use discount code: REGISTRATIONOPEN ‍ (Valid until 5th December 2026) ‍ Standard Rate : SGD 2,395 Use discount code: STANDARD ‍ (Valid until 6th February 2026) ‍ Final Call Rate : SGD 2,595 ‍ ‍ ‍Applicable to company profiles (headquartered outside of the APAC region): Academic Institutions Research Organisations ‍Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations Early Bird Rate : SGD 4,295 Use discount code: EARLYBIRD ‍ (Valid until 3rd October 2026) ‍ ‍ Registration Open Rate : SGD 4,495 Use discount code: REGISTRATIONOPEN ‍ (Valid until 5th December 2026) ‍ Standard Rate : SGD 4,695 Use discount code: STANDARD ‍ (Valid until 6th February 2026) ‍ Final Call Rate : SGD 4,895 ‍ Applicable to company profiles: Technology, Service, and Solution Providers ‍Job Profiles: Business Development, Marketing, and Sales Be the first in line! Register your interest to get access to tickets as soon as they go live. Want to Sponsor This Event? Contact the IMAPAC to learn about our sponsorship process, rates and more. Pre Conference Workshops & Other Sessions Visit the event page to view more content. Related Content Download content relating to this event and topic. Click to enlarge image Frequently Asked Questions Biopharma APAC Confex (Biopharma Asia Pacific Conference, Exhibition & Awards) is a regional life sciences platform that brings together biopharmaceutical, contract service providers, technology companies, investors, and industry leaders from across Asia-Pacific. The event combines a conference, exhibition, and awards programme to facilitate learning, networking, partnerships, and business development. Yes. Biologics manufacturing is a key pillar of the event, covering upstream processing, downstream processing, manufacturing strategy, MSAT, process development, CMC, quality, engineering, and supply chain management. Traditional bioprocessing conferences focus primarily on manufacturing and process development. Biopharma APAC Confex expands beyond manufacturing to include ADCs, cell & gene therapy, clinical trials, TIDES, supply chain, and broader business and partnering opportunities. The right event depends on your focus area. Professionals focused primarily on upstream and downstream processing may look at dedicated bioprocessing conferences. Those seeking broader exposure across biologics manufacturing, ADCs, cell & gene therapy, clinical development, supply chain, and outsourcing may benefit from attending Biopharma APAC Confex. Technology providers often participate in events that combine technical content with exhibition and networking opportunities. Yes. The exhibition welcomes technology providers, CDMOs, CROs, equipment suppliers, .software companies, consulting firms, logistics providers, and other organisations supporting the biopharma value chain The Biopharma APAC Awards recognise excellence, innovation, leadership, and achievement across the pharmaceutical, biotechnology, manufacturing, clinical development, and supply chain sectors in Asia-Pacific. Yes. Sponsors can use the event platform and networking tools to connect with attendees, schedule meetings, and identify potential customers, partners, or collaborators. Meeting availability may depend on the sponsorship package selected. Yes. Exhibitors and sponsors can access lead retrieval functionality through the event platform, enabling them to capture attendee information and efficiently manage follow-up activities after the event. Lead retrieval helps exhibitors identify prospects, track booth engagement, and measure event ROI. To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements. We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority. We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines. The event is designed for professionals working in: Biologics Manufacturing | Bioprocessing & Process Development | Cell & Gene Therapy ADC & Bioconjugates | Clinical Development & Clinical Operations | Supply Chain & Logistics Quality & Regulatory Affairs | CMC & Technical Operations | Digital Transformation & AI | Business Development & Strategic Partnerships The event covers six core industry pillars: Biologics Manufacturing ADC & Bioconjugates Cell & Gene Therapy (CGT) Clinical Trials Oligos & Peptides Additional topics include AI, digital transformation, and automation. Networking takes place through a combination of: Pre-scheduled one-to-one meetings Networking breaks Exhibition interaction Roundtable discussions Social functions and receptions The event app's attendee messaging and meeting platform. The event is designed to facilitate meaningful business conversations across the biopharma ecosystem. Yes. Biopharma APAC Confex provides a dedicated event app designed to help attendees, exhibitors, speakers, and sponsors maximise their experience before, during, and after the event. The app allows participants to view the agenda, connect with attendees, schedule meetings, receive event updates, and navigate the exhibition and conference programmes. Yes. Registered participants can use the event app to identify relevant attendees and arrange meetings in advance. This helps delegates, exhibitors, and sponsors plan their schedules and maximise networking opportunities throughout the event. Asia-Pacific hosts several pharmaceutical and biotechnology conferences each year. Biopharma APAC Confex distinguishes itself by bringing together biologics manufacturing, ADCs, cell & gene therapy, clinical trials, Oligos & Peptides, and supply chain professionals under a single platform. While Bioprocess International is primarily focused on bioprocessing and biologics manufacturing, Biopharma APAC Confex takes a broader ecosystem approach by combining manufacturing, advanced therapeutics, clinical development, outsourcing, supply chain, and commercialisation discussions within one event. Biopharma APAC Confex brings together manufacturing operations leaders, MSAT professionals, process development experts, CMC specialists, quality teams, supply chain leaders, and technology providers from across Asia-Pacific, making it a valuable networking and business development platform for the biologics industry. Yes, we offer sponsorship and exhibition opportunities for businesses and organisations. To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines. Be a Part of This Event! Don't miss out on unique networking, speaking and sponsorship opportunities. Connect with us on WeChat Scan this QR code using WeChat or WeCom to connect with our team. FOK YIH KEIT KAETHE IMAPAC